Literature DB >> 15922896

Risks of blood transfusion.

Lawrence T Goodnough1.   

Abstract

This article discusses advances in blood safety during the last 20 years, particularly for prevention of transfusion-transmitted viral infections. Although the most serious known risks from blood transfusion are administrative errors, transfusion-related acute lung injury, and bacterial contamination in platelet products, infection from emerging pathogens such as West Nile virus emphasizes the need for implementing proactive strategies. Pathogen inactivation technologies and reactive strategies such as nucleic acid testing ensure continued advances in blood safety.

Entities:  

Mesh：

Year:  2005        PMID： 15922896     DOI： 10.1016/j.atc.2004.07.004

Source DB:  PubMed          Journal:  Anesthesiol Clin North Am        ISSN： 0889-8537


  26 in total

Review 1.  Septic shock during platelet transfusion in a patient with acute myeloid leukaemia.

Authors:  Julie Haesebaert; Thomas Bénet; Mauricette Michallet; Philippe Vanhems
Journal:  BMJ Case Rep       Date:  2013-10-30

2.  The Yin and Yang of Blood Transfusion.

Authors:  Aryeh Shander; Tamara Friedman
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

3.  Transfusion-Related Acute Lung Injury (TRALI): Report of 2 Cases and a Review of The Literature.

Authors:  Bobby D Nossaman
Journal:  Ochsner J       Date:  2008

4.  Temporally and regionally disparate differences in plasmin activity by tranexamic acid.

Authors:  Daryl L Reust; Scott T Reeves; James H Abernathy; Jennifer A Dixon; William F Gaillard; Rupak Mukherjee; Christine N Koval; Robert E Stroud; Francis G Spinale
Journal:  Anesth Analg       Date:  2010-03-01       Impact factor: 5.108

5.  Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro Study.

Authors:  Majed A Refaai; Kelly F Henrichs; Sherry L Spinelli; Richard P Phipps; Edward Masel; Brian H Smith; Charles W Francis; Neil Blumberg
Journal:  US Oncol Hematol       Date:  2011-01-01

6.  Use of patient-specific cutting blocks reduces blood loss after total knee arthroplasty.

Authors:  Vicente J León; María A Lengua; Víctor Calvo; Alonso J Lisón
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-12-20

7.  Continuous localized monitoring of plasmin activity identifies differential and regional effects of the serine protease inhibitor aprotinin: relevance to antifibrinolytic therapy.

Authors:  Daryl L Reust; Jennifer A Dixon; Richard A McKinney; Risha K Patel; William T Rivers; Rupak Mukherjee; Robert E Stroud; Karen Madden; Kevin Groves; Milind Rajopadhye; Scott T Reeves; James H Abernathy; Francis G Spinale
Journal:  J Cardiovasc Pharmacol       Date:  2011-04       Impact factor: 3.105

8.  Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial.

Authors:  Johannes Cip; Mark Widemschek; Thomas Benesch; Roman Waibel; Arno Martin
Journal:  Clin Orthop Relat Res       Date:  2012-12-11       Impact factor: 4.176

Review 9.  Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Authors:  Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Mike J Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Maryann Napoli; Dirk Rades; David Steensma; Benjamin Djulbegovic; Martin F Fey; Isabelle Ray-Coquard; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents.

Authors:  Matthew A Weir; Tara Gomes; Eric Winquist; David N Juurlink; Meaghan S Cuerden; Muhammad Mamdani
Journal:  J Oncol Pract       Date:  2012-01-17       Impact factor: 3.840
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.